Creative Medical Technology Holdings, Inc. Interest Expense
Creative Medical Technology Holdings, Inc. (CELZ) reported Interest Expense of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-10
- Creative Medical Technology Holdings, Inc. interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. interest expense for the quarter ending 2023-03-31 was $50.00.
- Creative Medical Technology Holdings, Inc. interest expense for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. interest expense for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. interest expense for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Creative Medical Technology Holdings, Inc. interest expense for fiscal 2021 was $4.28M, a 247.96% increase from fiscal 2020.
- Creative Medical Technology Holdings, Inc. interest expense for fiscal 2020 was $1.23M, a 35.13% decline from fiscal 2019.
- Creative Medical Technology Holdings, Inc. interest expense for fiscal 2019 was $1.90M, a 39.23% increase from fiscal 2018.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | |||
| 2023-03-31 | $50.00 10-Q · filed 2024-05-10 | $50.00 derived: sum of 2 quarters · filed 2024-05-10 | $50.00 derived: sum of 3 quarters · filed 2024-05-10 | $50.00 derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $2.40M derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | $2.40M derived: sum of 3 quarters · filed 2023-05-12 | $3.71M derived: sum of 4 quarters · filed 2023-05-12 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $2.40M derived: sum of 2 quarters · filed 2023-05-12 | $3.71M derived: sum of 3 quarters · filed 2023-05-12 | $3.94M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.71M derived: sum of 2 quarters · filed 2023-03-31 | $3.94M derived: sum of 3 quarters · filed 2023-03-31 | $4.28M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.31M 10-Q · filed 2022-11-10 | $1.54M derived: sum of 2 quarters · filed 2022-11-10 | $1.88M 10-Q · filed 2022-11-10 | $2.20M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $234.34K 10-Q · filed 2022-08-12 | $570.41K 10-Q · filed 2022-08-12 | $889.77K derived: sum of 3 quarters · filed 2022-08-12 | $1.18M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $336.08K 10-Q · filed 2022-05-13 | $655.43K derived: sum of 2 quarters · filed 2022-05-13 | $944.64K derived: sum of 3 quarters · filed 2022-05-13 | $1.24M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $319.35K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $608.56K derived: sum of 2 quarters · filed 2022-03-30 | $906.37K derived: sum of 3 quarters · filed 2022-03-30 | $1.23M 10-K · filed 2022-03-30 |
| 2020-09-30 | $289.21K 10-Q · filed 2021-11-15 | $587.01K derived: sum of 2 quarters · filed 2021-11-15 | $910.24K 10-Q · filed 2021-11-15 | $1.32M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $297.80K 10-Q · filed 2021-08-16 | $621.03K 10-Q · filed 2021-08-16 | $1.03M derived: sum of 3 quarters · filed 2021-08-16 | $1.56M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $323.22K 10-Q · filed 2021-05-17 | $730.77K derived: sum of 2 quarters · filed 2021-05-17 | $1.26M derived: sum of 3 quarters · filed 2021-05-17 | $1.76M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $407.54K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $936.73K derived: sum of 2 quarters · filed 2021-03-17 | $1.44M derived: sum of 3 quarters · filed 2021-03-17 | $1.90M 10-K · filed 2021-03-17 |
| 2019-09-30 | $529.19K 10-Q · filed 2020-11-13 | $1.03M derived: sum of 2 quarters · filed 2020-11-13 | $1.49M 10-Q · filed 2020-11-13 | $1.87M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $504.25K 10-Q · filed 2020-08-14 | $958.80K 10-Q · filed 2020-08-14 | $1.34M derived: sum of 3 quarters · filed 2020-08-14 | $1.72M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $454.54K 10-Q · filed 2020-05-15 | $834.63K derived: sum of 2 quarters · filed 2020-05-15 | $1.21M derived: sum of 3 quarters · filed 2020-05-15 | $1.62M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $380.09K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $757.12K derived: sum of 2 quarters · filed 2020-04-06 | $1.17M derived: sum of 3 quarters · filed 2020-04-06 | $1.36M 10-K · filed 2020-04-06 |
| 2018-09-30 | $377.04K 10-Q · filed 2019-11-14 | $790.03K derived: sum of 2 quarters · filed 2019-11-14 | $981.34K 10-Q · filed 2019-11-14 | $1.16M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $413.00K 10-Q · filed 2019-08-13 | $604.30K 10-Q · filed 2019-08-13 | $786.37K derived: sum of 3 quarters · filed 2019-08-13 | $916.14K derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $191.31K 10-Q · filed 2019-05-20 | $373.37K derived: sum of 2 quarters · filed 2019-05-20 | $503.15K derived: sum of 3 quarters · filed 2019-05-20 | $566.39K derived: sum of 4 quarters · filed 2019-05-20 |
| 2017-12-31 | $182.06K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $311.84K derived: sum of 2 quarters · filed 2019-04-01 | $375.08K derived: sum of 3 quarters · filed 2019-04-01 | $377.59K 10-K · filed 2019-04-01 |
| 2017-09-30 | $129.78K 10-Q · filed 2018-11-14 | $193.02K derived: sum of 2 quarters · filed 2018-11-14 | $195.52K 10-Q · filed 2018-11-14 | $198.08K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $63.24K 10-Q · filed 2018-08-14 | $65.75K 10-Q · filed 2018-08-14 | $68.31K derived: sum of 3 quarters · filed 2018-08-14 | $70.28K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $2.50K 10-Q · filed 2018-08-03 | $5.07K derived: sum of 2 quarters · filed 2018-08-03 | $7.04K derived: sum of 3 quarters · filed 2018-08-03 | $8.19K derived: sum of 4 quarters · filed 2018-08-03 |
| 2016-12-31 | $2.56K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $4.53K derived: sum of 2 quarters · filed 2018-03-29 | $5.68K derived: sum of 3 quarters · filed 2018-03-29 | $6.40K 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.97K 10-Q · filed 2017-11-13 | $3.12K derived: sum of 2 quarters · filed 2017-11-13 | $3.84K 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $1.15K 10-Q · filed 2017-08-14 | $1.87K 10-Q · filed 2017-08-14 | ||
| 2011-09-30 | -$42.00 10-Q · filed 2011-10-31 | -$42.00 10-Q · filed 2011-10-31 | ||
| 2010-09-30 | $0.00 10-Q · filed 2011-10-31 | $0.00 10-Q · filed 2011-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |